Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Professor Saad Shakir
With
Merck Sharp & Dohme LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients for whom a study questionnaire containing useful information has been returned
You may not be if
Patients who do not provide consent
Patients within selected institutions (for example prisons)
Patients who commenced treatment between date of market launch (to be confirmed) and study start
Enrolled patients for whom both the baseline and 12-week questionnaires are returned blank (contain no clinical information)
Enrolled patients for whom the psychiatrist, designated member of clinical care team, or study facilitator from the DSRU reports that the patient did not take or was never prescribed asenapine
Enrolled patients for whom there is evidence to suggest duplication of patients
Enrolled patients for whom informed written or verbal notification is received by DSRU indicating that they no longer wish to participate at any stage of the study
